167 related articles for article (PubMed ID: 12646547)
1. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion.
MacLennan AH; Wilson DH; Taylor AW
Climacteric; 1998 Mar; 1(1):42-9. PubMed ID: 11907925
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and glucose tolerance in EPIC-Norfolk: a population-based study.
Sargeant LA; Wareham NJ; Khaw KT
Diabetes Metab Res Rev; 2000; 16(1):20-5. PubMed ID: 10707035
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins.
Vadlamudi S; MacLean P; Israel RG; Marks RH; Hickey M; Otvos J; Barakat H
Metabolism; 1998 Oct; 47(10):1222-6. PubMed ID: 9781625
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement and menopausal symptoms following hysterectomy.
Langenberg P; Kjerulff KH; Stolley PD
Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
[TBL] [Abstract][Full Text] [Related]
10. The relationship between fat distribution and coronary risk factors in sedentary postmenopausal women on and off hormone replacement therapy.
Perry AC; Allison M; Applegate EB; Jackson ML; Miller PC
Obes Res; 1998 Jan; 6(1):40-6. PubMed ID: 9526969
[TBL] [Abstract][Full Text] [Related]
11. Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.
Knuiman MW; Vu HT
J Epidemiol Community Health; 1997 Oct; 51(5):515-9. PubMed ID: 9425461
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
[TBL] [Abstract][Full Text] [Related]
13. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women.
Dallongeville J; Marecaux N; Isorez D; Zylbergberg G; Fruchart JC; Amouyel P
Atherosclerosis; 1995 Nov; 118(1):123-33. PubMed ID: 8579622
[TBL] [Abstract][Full Text] [Related]
14. Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy.
Rajman I; Lip GY; Cramb R; Maxwell SR; Zarifis J; Beevers DG; Kendall MJ
QJM; 1996 Oct; 89(10):771-8. PubMed ID: 8944233
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone replacement therapy use by older Mexican-American women.
Newell DA; Markides KS; Ray LA; Freeman JL
J Am Geriatr Soc; 2001 Aug; 49(8):1046-51. PubMed ID: 11555065
[TBL] [Abstract][Full Text] [Related]
16. Older women and hormone replacement therapy: factors influencing late life initiation.
Leveille SG; LaCroix AZ; Newton KM; Keenan NL
J Am Geriatr Soc; 1997 Dec; 45(12):1496-500. PubMed ID: 9400560
[TBL] [Abstract][Full Text] [Related]
17. Are long-term hormone replacement therapy users different from short-term and never users?
Buist DS; LaCroix AZ; Newton KM; Keenan NL
Am J Epidemiol; 1999 Feb; 149(3):275-81. PubMed ID: 9927224
[TBL] [Abstract][Full Text] [Related]
18. Disparities in hormone replacement therapy use by socioeconomic status in a primary care population.
Finley C; Gregg EW; Solomon LJ; Gay E
J Community Health; 2001 Feb; 26(1):39-50. PubMed ID: 11297189
[TBL] [Abstract][Full Text] [Related]
19. Do women using hormone replacement treatment have less pre-existing cardiovascular risk.
Blümel JE; Castelo-Branco C; Roncagliolo ME; Guanes PP; Lavin P
Maturitas; 2001 May; 38(3):315-9. PubMed ID: 11358649
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy use in urban older women attending meal sites: associations with sociodemographic and health characteristics and use of preventive services.
Ganesan K; Teklehaimanot S; Swartz JB; Reuben DB
J Am Geriatr Soc; 2000 Jun; 48(6):669-72. PubMed ID: 10855604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
